Keyword Analysis & Research: genzyme products
Keyword Research: People who searched genzyme products also searched
Search Results related to genzyme products on Search Engine
-
Genzyme - Wikipedia
https://en.wikipedia.org/wiki/Genzyme
WEBAs a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market.
DA: 18 PA: 58 MOZ Rank: 28
-
Our Products and Resources | Sanofi USA
https://www.sanofi.us/en/your-health/products
WEBAt Sanofi, we provide a range of healthcare products, including prescription medicines, vaccines, generics, and resources.
DA: 50 PA: 87 MOZ Rank: 94
-
Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
https://www.sanofi.us/en
WEBHealth Equity Starts with Listening. We know that for people to live their healthiest lives possible, there must be an ecosystem that provides a continuum of care. Sanofi’s CSR and DEI teams have prioritized engaging communities across the country in listening sessions in order to provide resources that address the specific needs of each ...
DA: 100 PA: 60 MOZ Rank: 90
-
Our Oncology Products - Working to Improve the Lives of People …
https://www.sanofioncology.com/products/
WEBAll infusion-related reactions resolved: within the same day in 74% of episodes, and the day after in 24% of episodes. The most common symptoms (≥5%) of an infusion-related reaction in ICARIA-MM and IKEMA (N=329) included dyspnea, cough, nasal congestion, and nausea. Anaphylactic reactions occurred in less than 1% of patients.
DA: 49 PA: 79 MOZ Rank: 65
-
Exploring Our Prescription Product Information | Sanofi USA
https://www.sanofi.us/en/your-health/products/prescription-products
WEBExplore Sanofi's comprehensive list of prescription product information, tailored to meet diverse healthcare needs.
DA: 92 PA: 54 MOZ Rank: 27
-
FDA Approves New Treatment for Pompe Disease | FDA
https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-pompe-disease
WEBAug 6, 2021 · Today the FDA approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
DA: 25 PA: 78 MOZ Rank: 10
-
FDA approves Nexviazyme® (avalglucosidase alfa-ngpt), an
https://www.sanofi.com/en/media-room/press-releases/2021/2021-08-06-15-42-21-2276588
WEBAug 6, 2021 · Approval is based on positive Phase 3 data demonstrating improvements in key disease burden measures and establishing its safety profile. Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells.
DA: 11 PA: 92 MOZ Rank: 44
-
FDA Approves Sanofi Genzyme’s Nexviazyme for Treatment of
https://mdaquest.org/fda-approves-sanofi-genzymes-nexviazyme-for-treatment-of-pompe-disease/
WEBOn Aug. 6, the US Food and Drug Administration (FDA) granted accelerated marketing approval to avalglucosidase alfa (Nexviazyme) for the treatment of people 1 year of age and older living with late-onset Pompe disease. It is the second approved drug to treat Pompe disease.
DA: 93 PA: 96 MOZ Rank: 24
-
Immunology and Inflammation - Sanofi
https://www.sanofi.com/en/your-health/medicines/immunology
WEBImmunology and Inflammation. We delivered the first advanced biologic for atopic dermatitis. Now we’re following the science to get inflammation under control and restore immune balance in many other diseases. Our families, friends, and neighbors who are affected by chronic inflammatory diseases are depending on us to transform their lives.
DA: 47 PA: 66 MOZ Rank: 64
-
Genzyme’s Alemtuzumab for Treatment of Multiple ... - Fierce …
https://www.fiercepharma.com/pharma/genzyme-s-alemtuzumab-for-treatment-multiple-sclerosis-granted-fast-track-status-by-fda
WEBJun 14, 2010 5:18pm. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Genzyme Corporation (Nasdaq: GENZ) announced today that its alemtuzumab for multiple sclerosis development program has been granted Fast ...
DA: 83 PA: 51 MOZ Rank: 22
